{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:44:03Z","timestamp":1793036643596,"version":"4.5.0"},"reference-count":22,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022274","name":"Daiichi Sankyo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100022274","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/027y26122","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Sciences"],"abstract":"<jats:p>Background: Asymptomatic atrial fibrillation (AF) represents a substantial proportion of diagnosed AF cases; however, its prognostic implications remain controversial. This study aimed to compare clinical characteristics, treatment strategies, and outcomes between asymptomatic and symptomatic AF patients in a contemporary real-world registry. Methods: This observational subanalysis included 997 patients from the prospective multicenter REGUEIFA registry with 2-year follow-up. Patients were classified as asymptomatic if they had a baseline European Heart Rhythm Association (EHRA) score of I. Clinical characteristics, therapeutic strategies, and the incidence of a composite endpoint including cardiovascular death, stroke, major bleeding, or worsening heart failure were analyzed. Results: Overall, 33.7% of patients were asymptomatic. Compared with symptomatic patients, asymptomatic patients had a lower prevalence of heart failure, hypertension, and cardiomyopathy, lower CHA2DS2-VASc scores, and a higher prevalence of preserved left ventricular ejection fraction. Rhythm control strategies were less frequently used in asymptomatic patients (58.33% vs. 65.96%; p = 0.018), despite similar arrhythmia recurrence rates after treatment (p = 0.490). The incidence of the composite endpoint was lower in asymptomatic patients (8.39 [6.53\u201310.78] vs. 12.12 [10.43\u201314.09] per 100 person-years; p = 0.013), mainly driven by lower cardiovascular mortality. No significant differences were observed in stroke, major bleeding, worsening heart failure, or all-cause mortality. In multivariable analysis adjusted for clinically relevant covariates, symptomatic patients exhibited a higher incidence of the composite endpoint. Conclusions: In this contemporary real-world registry, asymptomatic AF patients exhibited a lower burden of cardiovascular comorbidities and lower cardiovascular mortality than symptomatic patients, while rates of stroke, heart failure worsening, major bleeding, and arrhythmia recurrence were similar. These findings suggest that prognosis is influenced predominantly by baseline comorbidity burden, and the independent contribution of symptom status itself, although statistically significant, appears modest and should be interpreted with caution given the observational design.<\/jats:p>","DOI":"10.3390\/medsci14030401","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:09:09Z","timestamp":1784527749000},"page":"401","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Asymptomatic Atrial Fibrillation in Contemporary Clinical Practice: Insights from the REGUEIFA Registry"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3628-6245","authenticated-orcid":false,"given":"Carlos","family":"Minguito-Carazo","sequence":"first","affiliation":[{"name":"Department of Cardiology, Hospital Universitario de Santiago de Compostela, 15706 Santiago de Compostela, Spain"},{"name":"Cellular and Molecular Cardiology Unit, Health Research Institute of Santiago de Compostela (IDIS-SERGAS), 15706 Santiago de Compostela, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4065-221X","authenticated-orcid":false,"given":"Laila","family":"Gonz\u00e1lez Melchor","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Universitario Lucus Augusti, Health Research Institute of Santiago (IDIS), 27001 Lugo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"V\u00e1zquez Caama\u00f1o","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital San Rafael, 15006 A Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Fern\u00e1ndez-Obanza Windcheid","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital \u00c1lvaro Cunqueiro and Health Research Institute of Southern Galicia (IISGS), 36312 Vigo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Marzoa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Arquitecto Marcide, 15405 Ferrol, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Pi\u00f1eiro Portela","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Biomedical Research Institute of A Coru\u00f1a (INIBIC), Hospital Universitario de A Coru\u00f1a, 15006 A Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Gonz\u00e1lez Babarro","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Universitario Montecelo, 36164 Pontevedra, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Cabanas Grand\u00edo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital \u00c1lvaro Cunqueiro and Health Research Institute of Southern Galicia (IISGS), 36312 Vigo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Dur\u00e1n Bob\u00edn","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Universitario Lucus Augusti, Health Research Institute of Santiago (IDIS), 27001 Lugo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2987-003X","authenticated-orcid":false,"given":"\u00d3scar","family":"Prada Delgado","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Biomedical Research Institute of A Coru\u00f1a (INIBIC), Hospital Universitario de A Coru\u00f1a, 15006 A Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Elices","family":"Tejada","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Universitario Lucus Augusti, Health Research Institute of Santiago (IDIS), 27001 Lugo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evaristo","family":"Freire","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Universitario de Ourense, 32003 Ourense, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4455-0704","authenticated-orcid":false,"given":"Mario","family":"Guti\u00e9rrez Feijoo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Universitario de Ourense, 32003 Ourense, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Mu\u00f1iz","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, 28029 Madrid, Spain"},{"name":"Cardiovascular Research Group, Department of Health Sciences and Biomedical Research Institute of a Coru\u00f1a (INIBIC), University of A Coru\u00f1a, CIBERCV, 15006 A Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Gude","sequence":"additional","affiliation":[{"name":"Research Methodology Group, Health Research Institute of Santiago (IDIS), University of Santiago de Compostela (USC), 15706 Santiago de Compostela, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Barge Caballero","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, 28029 Madrid, Spain"},{"name":"Department of Cardiology, Biomedical Research Institute of A Coru\u00f1a (INIBIC), Hospital Universitario de A Coru\u00f1a, 15006 A Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4483-9778","authenticated-orcid":false,"given":"Carlos","family":"Gonz\u00e1lez-Juanatey","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Universitario Lucus Augusti, Health Research Institute of Santiago (IDIS), 27001 Lugo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7903-9490","authenticated-orcid":false,"given":"Javier","family":"Garc\u00eda Seara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Universitario de Santiago de Compostela, 15706 Santiago de Compostela, Spain"},{"name":"Cellular and Molecular Cardiology Unit, Health Research Institute of Santiago de Compostela (IDIS-SERGAS), 15706 Santiago de Compostela, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,18]]},"reference":[{"key":"ref_1","first-page":"100786","article-title":"Atrial fibrillation: Epidemiology, screening and digital health","volume":"37","author":"Linz","year":"2024","journal-title":"Lancet Reg. Health-Eur."},{"key":"ref_2","first-page":"561","article-title":"Epidemiology of Atrial Fibrillation in Spain in the Past 20 Years","volume":"66","year":"2013","journal-title":"Rev. Espa\u00f1ola Cardiol. (Engl. Ed.)"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Pamporis, K., Karakasis, P., Sagris, M., Theofilis, P., Milaras, N., Pantelidaki, A., Mourouzis, I., Fragakis, N., Vlachos, K., and Kordalis, A. (2025). Prevalence of asymptomatic atrial fibrillation and risk factors associated with asymptomatic status: A systematic review and meta-analysis. Eur. J. Prev. Cardiol., zwaf138.","DOI":"10.1093\/eurjpc\/zwaf138"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.amjmed.2014.11.026","article-title":"Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry","volume":"128","author":"Boriani","year":"2015","journal-title":"Am. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early Rhythm-Control Therapy in Patients with Atrial Fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_6","first-page":"3314","article-title":"ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): Developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO)","volume":"45","author":"Rienstra","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_7","first-page":"e1","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2023","journal-title":"Circulation"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.rccl.2020.10.015","article-title":"Dise\u00f1o y caracter\u00edsticas basales del estudio REGUEIFA (Registro Gallego Interc\u00e9ntrico de Fibrilaci\u00f3n Auricular)","volume":"56","author":"Windcheid","year":"2021","journal-title":"REC CardioClinics"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/jce.16108","article-title":"Does asymptomatic atrial fibrillation exist?","volume":"35","author":"Carneiro","year":"2024","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/eurheartj\/ehae694","article-title":"Major clinical outcomes in symptomatic vs. asymptomatic atrial fibrillation: A meta-analysis","volume":"46","author":"Karakasis","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejim.2023.09.009","article-title":"Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients","volume":"119","author":"Boriani","year":"2024","journal-title":"Eur. J. Intern. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.chest.2017.08.004","article-title":"Clinical Impact of Asymptomatic Presentation Status in Patients with Paroxysmal and Sustained Atrial Fibrillation: The Fushimi AF Registry","volume":"152","author":"Esato","year":"2017","journal-title":"Chest"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.amjmed.2021.01.017","article-title":"Clinical Outcomes in Asymptomatic and Symptomatic Atrial Fibrillation Presentations in GARFIELD-AF: Implications for AF Screening","volume":"134","author":"Gibbs","year":"2021","journal-title":"Am. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.amjcard.2024.02.026","article-title":"Association Between Atrial Fibrillation Symptoms and Clinical Outcomes: A Prospective Multicenter Registry Study","volume":"217","author":"Lee","year":"2024","journal-title":"Am. J. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/CIRCOUTCOMES.114.001303","article-title":"Association between Atrial Fibrillation Symptoms, Quality of Life, and Patient Outcomes: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)","volume":"8","author":"Freeman","year":"2015","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.amjcard.2018.07.045","article-title":"Embolic and Other Adverse Outcomes in Symptomatic Versus Asymptomatic Patients With Atrial Fibrillation (from the ORBIT-AF Registry)","volume":"122","author":"Thind","year":"2018","journal-title":"Am. J. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Sgreccia, D., Manicardi, M., Malavasi, V.L., Vitolo, M., Valenti, A.C., Proietti, M., Lip, G.Y.H., and Boriani, G. (2021). Comparing Outcomes in Asymptomatic and Symptomatic Atrial Fibrillation: A Systematic Review and Meta-Analysis of 81,462 Patients. J. Clin. Med., 10.","DOI":"10.3390\/jcm10173979"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e007414","DOI":"10.1161\/CIRCEP.119.007414","article-title":"Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"12","author":"Asad","year":"2019","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/jamacardio.2021.0852","article-title":"Assessment of Catheter Ablation or Antiarrhythmic Drugs for First-line Therapy of Atrial Fibrillation: A Meta-analysis of Randomized Clinical Trials","volume":"6","author":"Turagam","year":"2021","journal-title":"JAMA Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/eurheartj\/ehab593","article-title":"Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: The EAST-AFNET 4 trial","volume":"43","author":"Willems","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1161\/CIRCULATIONAHA.104.518837","article-title":"Perception of atrial fibrillation before and after radiofrequency catheter ablation: Relevance of asymptomatic arrhythmia recurrence","volume":"112","author":"Hindricks","year":"2005","journal-title":"Circulation"},{"key":"ref_22","first-page":"255","article-title":"Symptomatic and silent atrial fibrillation recurrences after pulmonary vein isolation ablation\u2014Usefulness of prolonged 7-day Holter recordings. One-center observation","volume":"15","author":"Wita","year":"2019","journal-title":"Postep. Kardiol. Interwencyjnej"}],"container-title":["Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3271\/14\/3\/401\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:18:03Z","timestamp":1784607483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3271\/14\/3\/401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["medsci14030401"],"URL":"https:\/\/doi.org\/10.3390\/medsci14030401","relation":{},"ISSN":["2076-3271"],"issn-type":[{"value":"2076-3271","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,18]]}}}